Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2003 1
2010 1
2011 1
2012 2
2014 2
2015 2
2017 1
2018 2
2019 1
2020 1
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Acute episodes of neuropathic symptoms"
Page 1
Advances in the diagnosis and management of neck pain.
Cohen SP, Hooten WM. Cohen SP, et al. BMJ. 2017 Aug 14;358:j3221. doi: 10.1136/bmj.j3221. BMJ. 2017. PMID: 28807894 Review.
Neck pain imposes a considerable personal and socioeconomic burden-it is one of the top five chronic pain conditions in terms of prevalence and years lost to disability-yet it receives a fraction of the research funding given to low back pain. Although most acute episod …
Neck pain imposes a considerable personal and socioeconomic burden-it is one of the top five chronic pain conditions in terms of prevalence …
Neuropathic pain in individuals with sickle cell disease.
Sharma D, Brandow AM. Sharma D, et al. Neurosci Lett. 2020 Jan 1;714:134445. doi: 10.1016/j.neulet.2019.134445. Epub 2019 Aug 24. Neurosci Lett. 2020. PMID: 31454562 Review.
Pain is the most frequently occurring complication of sickle cell disease (SCD) and the leading cause of hospitalizations for affected individuals. Acute pain episodes are also an independent predictor of mortality in individuals with SCD. ...In spite of this …
Pain is the most frequently occurring complication of sickle cell disease (SCD) and the leading cause of hospitalizations for affected indiv …
Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: A retrospective analysis of 144 cases.
Muñoz-Vendrell A, Teixidor S, Sala-Padró J, Campoy S, Huerta-Villanueva M. Muñoz-Vendrell A, et al. Cephalalgia. 2022 Sep;42(10):1031-1038. doi: 10.1177/03331024221092435. Epub 2022 Apr 26. Cephalalgia. 2022. PMID: 35469475 Free PMC article. Review.
Pain relief was observed in 77.8% of 63 patients receiving lacosamide infusions, and adverse effects in 1.6%. Pain relief was observed in 72.8% of 81 phenytoin infusions and adverse effects in 12.3%, all mild. ...
Pain relief was observed in 77.8% of 63 patients receiving lacosamide infusions, and adverse effects in 1.6%. Pain relief was obse …
Clinicopathological features of acute autonomic and sensory neuropathy.
Koike H, Atsuta N, Adachi H, Iijima M, Katsuno M, Yasuda T, Fukada Y, Yasui K, Nakashima K, Horiuchi M, Shiomi K, Fukui K, Takashima S, Morita Y, Kuniyoshi K, Hasegawa Y, Toribe Y, Kajiura M, Takeshita S, Mukai E, Sobue G. Koike H, et al. Brain. 2010 Oct;133(10):2881-96. doi: 10.1093/brain/awq214. Epub 2010 Aug 23. Brain. 2010. PMID: 20736188
Acute autonomic and sensory neuropathy is a rare disorder that has been only anecdotally reported. ...It tended to be asymmetrical and segmental, rather than presenting as a symmetric polyneuropathy. Pain of the involved region was a common and serious symptom. In a …
Acute autonomic and sensory neuropathy is a rare disorder that has been only anecdotally reported. ...It tended to be asymmetrical an …
Development of a screening tool to predict the risk of chronic pain and disability following musculoskeletal trauma: protocol for a prospective observational study in the United Kingdom.
Rushton AB, Evans DW, Middlebrook N, Heneghan NR, Small C, Lord J, Patel JM, Falla D. Rushton AB, et al. BMJ Open. 2018 Apr 28;8(4):e017876. doi: 10.1136/bmjopen-2017-017876. BMJ Open. 2018. PMID: 29705750 Free PMC article.
To achieve this, we will use a unique and comprehensive combination of patient-reported outcome measures, psychophysical testing and biomarkers. METHODS AND ANALYSIS: A prospective observational study will recruit two temporally staggered cohorts (n=250 each cohort; at lea …
To achieve this, we will use a unique and comprehensive combination of patient-reported outcome measures, psychophysical testing and biomark …
Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers.
Evans JW, Graves MC, Nugent AC, Zarate CA Jr. Evans JW, et al. Sci Rep. 2024 Feb 24;14(1):4538. doi: 10.1038/s41598-024-54370-9. Sci Rep. 2024. PMID: 38402253 Free PMC article.
Clinical studies have identified reduced volumes in MDD that are thought to be potentiated by early life stress and worsened by repeated depressive episodes. This study used 3T and 7T structural magnetic resonance imaging data to examine longitudinal changes in hippocampal …
Clinical studies have identified reduced volumes in MDD that are thought to be potentiated by early life stress and worsened by repeated dep …
Neuropathic pain during treatment for childhood acute lymphoblastic leukemia.
Anghelescu DL, Faughnan LG, Jeha S, Relling MV, Hinds PS, Sandlund JT, Cheng C, Pei D, Hankins G, Pauley JL, Pui CH. Anghelescu DL, et al. Pediatr Blood Cancer. 2011 Dec 15;57(7):1147-53. doi: 10.1002/pbc.23039. Epub 2011 Feb 11. Pediatr Blood Cancer. 2011. PMID: 21319291 Free PMC article.
RESULTS: White non-Hispanic race was the only patient variable predictive of NP. One hundred and seventy-four of 498 patients (34.9%) experienced 207 episodes of NP; 16% (28 of 174) patients experienced at least one recurrence of pain after the initial episode …
RESULTS: White non-Hispanic race was the only patient variable predictive of NP. One hundred and seventy-four of 498 patients (34.9%) …
One-year follow-up of patients with long-lasting post-herpetic neuralgia.
Pica F, Gatti A, Divizia M, Lazzari M, Ciotti M, Sabato AF, Volpi A. Pica F, et al. BMC Infect Dis. 2014 Nov 1;14:556. doi: 10.1186/s12879-014-0556-6. BMC Infect Dis. 2014. PMID: 25361823 Free PMC article.
RESULTS: At T0 all the patients were at least 6 months from the episode of acute zoster and still presented with intense pain (mean VAS =6.7; mean DN4 = 5.7). ...Undesirable side effects of analgesic therapies were observed in 15.3 to 28.8% of the patients. C …
RESULTS: At T0 all the patients were at least 6 months from the episode of acute zoster and still presented with intense pain …
Cognitive-Evaluative Dimension of Pain in Neuropathic Pain Relapse in Sciatica: A Case Report.
Kawasaki T, Yada T, Ohira M. Kawasaki T, et al. Medicina (Kaunas). 2021 Jun 27;57(7):658. doi: 10.3390/medicina57070658. Medicina (Kaunas). 2021. PMID: 34198991 Free PMC article.
A woman was diagnosed with low back pain (LBP) and sciatica. The patient had previously experienced symptoms of LBP and sciatica; thus, this episode was a case of pain relapse. ...The C-E dimension of pain was observed with pain relapse even though it was in …
A woman was diagnosed with low back pain (LBP) and sciatica. The patient had previously experienced symptoms of LBP and sciatica; thu …
Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.
Steigerwald I, Müller M, Davies A, Samper D, Sabatowski R, Baron R, Rozenberg S, Szczepanska-Szerej A, Gatti A, Kress HG. Steigerwald I, et al. Curr Med Res Opin. 2012 Jun;28(6):911-36. doi: 10.1185/03007995.2012.679254. Epub 2012 May 9. Curr Med Res Opin. 2012. PMID: 22443293 Clinical Trial.
OBJECTIVE: This open-label, phase 3b study evaluated the effectiveness and tolerability of tapentadol prolonged release and tapentadol immediate release (for acute pain episodes) for severe, chronic low back pain with or without a neuropathic pain component t …
OBJECTIVE: This open-label, phase 3b study evaluated the effectiveness and tolerability of tapentadol prolonged release and tapentadol immed …
16 results